Interstitial Pneumonitis After Everolimus Therapy for Renal Cell Carcinoma

---

Urhan E., Huzmeli C., Candan F., Seven D., Gumus C., Kayatas M.

TURKISH NEPHROLOGY DIALYSIS AND TRANSPLANTATION JOURNAL, cilt.25, ss.187-190, 2016 (ESCI)

• Yayın Türü: Makale / Tam Makale
• Cilt numarası: 25
• Basım Tarihi: 2016
• Doi Numarası: 10.5262/tndt.2016.46
• Dergi Adı: TURKISH NEPHROLOGY DIALYSIS AND TRANSPLANTATION JOURNAL
• Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
• Sayfa Sayıları: ss.187-190
• Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
• Sivas Cumhuriyet Üniversitesi Adresli: Evet

Özet

Everolimus is an immunosuppressive agent belonging to the mTOR inhibitors group, used in solid organ transplantation and renal cell carcinomas. The use of inhibitors of the mTOR group in renal carcinomas is associated with many side effects, the potentially most severe being interstitial pneumonitis. A 76-year-old female patient presented with exertional dyspnea, fever and cough. In this report, we discuss a patient with everolimus-induced interstitial pneumonia with a review of the relevant literature.